Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Extent of BM infiltration predicts progression in asymptomatic Waldenström macroglobulinemia; other factors = advanced age (HR 1.04), lower Hgb (1.02), elevated M protein and IgM (1.06), cytogenetic aberrations (HR 2.5).”
Title: Extent of bone marrow infiltration predicts disease progression in asymptomatic Waldenström macroglobulinemia
Authors: Nicolò Danesin, Giovanni Leone, Mattia D’Antiga, Greta Scapinello, Marco Carraro, Alessandro Cellini, Francesco Angotzi, Simone Zoletto, Laura Bonaldi, Fabrizio Vianello, Sabrina Manni, Marco Pizzi, Andrea Visentin, Livio Trentin, Francesco Piazza
You can read the Full Article in Discover Oncology.
You can find more posts featuring Robert Orlowski on OncoDaily.
